Doctor profile · Federal record
Dr. Nancy Krywonis, M.D.
Dermatology Physician (CMS: Dermatology) · Denver, CO
- NPI 1134260466
- Accepts Medicare
- MIPS 80.1 / 100 · 2023
- 42 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
4545 E 9Th Ave, Suite 420
Denver, CO 802203901
(303) 586-7768
fax (303) 957-3098 - Mailing address
-
7300 Ranch Road 2222, Building 1, Ste 200
Austin, TX 78730
Credentials & registration
- NPI registered
- February 2007 — 19 yrs on file
- Profile last updated
- February 24, 2023
- Year of graduation
- 1984 — 42 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Colorado #44212
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1134260466. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,862
Distinct HCPCS
10
Medicare allowed
$140,536
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 552 | 460 | $92 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 388 | 108 | $7 | |
17000 |
Destruction of precancer skin growth, 1 growth | 248 | 195 | $60 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 192 | 157 | $129 | |
11102 |
Biopsy of related skin growth, first growth | 141 | 124 | $101 | |
17110 |
Destruction of skin growth, 1-14 growths | 120 | 96 | $114 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 93 | 81 | $58 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 48 | 48 | $114 | |
11104 |
Punch biopsy, first skin growth | 33 | 32 | $126 | |
11103 |
Biopsy of related skin growth, each additional growth | 28 | 21 | $53 |
In context: peer comparison
Among 17 peers in this city , average services per provider: 128. This provider delivers 15× the peer median.Open Payments
Industry payments received
All-time total
$570
Transactions
25
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $122.42 | |
| GENZYME CORPORATION | 2 | $63.48 | |
| LEO Pharma Inc. | 3 | $52.29 | |
| ABBVIE INC. | 2 | $45.04 | |
| Dermavant Sciences, Inc. | 2 | $37.06 | |
| ConvaTec Inc. | 1 | $34.94 | |
| PFIZER INC. | 2 | $32.92 | |
| Arcutis Biotherapeutics, Inc. | 2 | $30.77 | |
| Lilly USA, LLC | 1 | $29.95 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $28.19 | |
| Verrica Pharmaceuticals Inc. | 1 | $20.17 | |
| UCB, Inc. | 1 | $20.15 | |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $19.14 | |
| Novartis Pharmaceuticals Corporation | 1 | $17.37 | |
| Janssen Biotech, Inc. | 1 | $15.98 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
175
Patients
100
Total drug cost
$5,265
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 68 | 52 | $521 |
| Imiquimod | Generic | 24 | 17 | $819 |
| Fluorouracil | Generic | 21 | 19 | $1,825 |
| Clobetasol Propionate | Generic | 18 | 12 | $1,363 |
| Ketoconazole | Generic | 18 | 0 | $304 |
| Minoxidil | Generic | 15 | 0 | $175 |
| Doxycycline Hyclate | Generic | 11 | 0 | $257 |
Frequently asked questions
What is Dr. Nancy Krywonis's medical specialty?
Dr. Nancy Krywonis practices Dermatology Physician in Denver, CO.
Where does Dr. Nancy Krywonis practice?
Dr. Nancy Krywonis practices at 4545 E 9Th Ave, Denver, CO 802203901. Office phone: 3035867768.
What is Dr. Nancy Krywonis's NPI?
Dr. Nancy Krywonis's National Provider Identifier (NPI) is 1134260466, issued by NPPES.
Does Dr. Nancy Krywonis accept Medicare assignment?
Yes. Dr. Nancy Krywonis accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Nancy Krywonis commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.